Search

Search Constraints

You searched for: Author/Creator ,

Search Results

1587. 71 Prediction of response to rituximab in SLE using a validated two-score system for interferon status. (April 2019)

1588. 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. Issue 8 (August 2022)